MXPA04011426A - Metodo para tratar la hepatitis. - Google Patents
Metodo para tratar la hepatitis.Info
- Publication number
- MXPA04011426A MXPA04011426A MXPA04011426A MXPA04011426A MXPA04011426A MX PA04011426 A MXPA04011426 A MX PA04011426A MX PA04011426 A MXPA04011426 A MX PA04011426A MX PA04011426 A MXPA04011426 A MX PA04011426A MX PA04011426 A MXPA04011426 A MX PA04011426A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- treating hepatitis
- patient
- hepatitis
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Inorganic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- External Artificial Organs (AREA)
- Saccharide Compounds (AREA)
Abstract
La presente invencion se refiere a un metodo para tratar la hepatitis en un paciente, el cual incluye administrar una composicion farmaceutica que incluye monoxido de carbono al paciente.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38152702P | 2002-05-17 | 2002-05-17 | |
PCT/US2003/015263 WO2003096977A2 (en) | 2002-05-17 | 2003-05-16 | Methods of treating hepatitis |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA04011426A true MXPA04011426A (es) | 2005-10-19 |
Family
ID=29550139
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA04011426A MXPA04011426A (es) | 2002-05-17 | 2003-05-16 | Metodo para tratar la hepatitis. |
Country Status (16)
Country | Link |
---|---|
US (4) | US20040052866A1 (es) |
EP (1) | EP1505990B1 (es) |
JP (1) | JP4549847B2 (es) |
CN (1) | CN1668314B (es) |
AT (1) | ATE521357T1 (es) |
CA (1) | CA2485465A1 (es) |
DK (1) | DK1505990T3 (es) |
EA (1) | EA200401525A1 (es) |
ES (1) | ES2372273T3 (es) |
HR (1) | HRP20041071A2 (es) |
MX (1) | MXPA04011426A (es) |
NO (1) | NO20045056L (es) |
PL (1) | PL205066B1 (es) |
RS (1) | RS99304A (es) |
UA (1) | UA83465C2 (es) |
WO (1) | WO2003096977A2 (es) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7678390B2 (en) * | 1999-04-01 | 2010-03-16 | Yale University | Carbon monoxide as a biomarker and therapeutic agent |
GB0111872D0 (en) * | 2001-05-15 | 2001-07-04 | Northwick Park Inst For Medica | Therapeutic agents and methods |
MXPA03012031A (es) * | 2001-06-21 | 2005-07-01 | Univ Yale | El monoxido de carbono mejoraresultados en transplantes de tejido y organo y suprime apoptosis. |
NZ534912A (en) * | 2002-02-04 | 2007-08-31 | Alfama Investigacao E Desenvol | supramolecule aggregate comprising CO containing organometallic or transition metal complex and anti-inflammatory agent or biphosphonate phosphonate derivative |
US7968605B2 (en) * | 2002-02-04 | 2011-06-28 | ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. | Methods for treating inflammatory disease by administering aldehydes and derivatives thereof |
US20080026984A1 (en) * | 2002-02-04 | 2008-01-31 | Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda | Methods for treating inflammatory disease by administering aldehydes and derivatives thereof |
WO2003088748A1 (en) | 2002-04-15 | 2003-10-30 | Beth Israel Deaconess Medical Center | Use of heme oxygenase-1 and products of heme degradation |
EP1499328B1 (en) * | 2002-04-15 | 2015-09-16 | University of Pittsburgh - Of the Commonwealth System of Higher Education | Methods of treating necrotizing enterocolitis |
PL373002A1 (en) * | 2002-04-15 | 2005-08-08 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Methods of treating ileus |
ES2372273T3 (es) | 2002-05-17 | 2012-01-17 | Yale University | Métodos de tratamiento de la hepatitis. |
PL374375A1 (en) * | 2002-06-05 | 2005-10-17 | Yale University | Methods of treating angiogenesis, tumor growth, and metastasis |
EA200500062A1 (ru) * | 2002-06-21 | 2005-06-30 | Юниверсити Оф Питтсбург Оф Дзе Коммонвелт Систем Оф Хайер Эдьюкейшн | Фармацевтическое применение оксида азота, гемоксигеназы-1 и продуктов деградации гема |
EA200500782A1 (ru) * | 2002-11-07 | 2005-10-27 | Юниверсити Оф Питтсбург Оф Дзе Коммонвелт Систем Оф Хайер Эдьюкейшн | Лечение геморрагического шока |
GB2395432B (en) * | 2002-11-20 | 2005-09-14 | Northwick Park Inst For Medica | Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs |
US20070207217A1 (en) * | 2003-02-03 | 2007-09-06 | Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda | Method for treating a mammal by administration of a compound having the ability to release CO |
US20040218547A1 (en) | 2003-04-30 | 2004-11-04 | Rhodey William George | Process modification to maximize benzene production |
US20070207993A1 (en) * | 2005-12-20 | 2007-09-06 | Alfama - Investigacao E Desenvolvimetno De Productos Farmaceuticos Lda | Molybdenum carbonyl complexes for treating rheumatoid arthritis and other inflammatory diseases |
WO2007073006A1 (ja) * | 2005-12-22 | 2007-06-28 | Keio University | 細胞保護性を有するアミノ酸の増加誘導剤及び増加方法 |
JPWO2007073005A1 (ja) * | 2005-12-22 | 2009-06-04 | 学校法人慶應義塾 | メチル基転移反応調節物質 |
GB0601394D0 (en) | 2006-01-24 | 2006-03-01 | Hemocorm Ltd | Therapeutic delivery of carbon monoxide |
AU2009298182B2 (en) * | 2008-10-03 | 2013-07-11 | The Charlotte-Mecklenburg Hospital Authority D/B/A Carolinas Medical Center | Treatment of hepatitis C infection with metalloporphyrins |
KR101661872B1 (ko) | 2009-05-27 | 2016-10-10 | 이노 테라퓨틱스 엘엘씨 | 인덱싱된 밸브와 압축 캐니스터 조립체를 칼라에 결합하고 플런저 조립체로 선형 작동시켜 약물 전달 조절용 장치와 유체 소통상태가 되게 하는 방법 및 장치 |
JP2011010865A (ja) | 2009-06-30 | 2011-01-20 | Ikaria Holdings Inc | 肺高血圧の臨床的または超音波心臓検査上の証拠を伴う低酸素性呼吸器不全に罹った満期産およびほぼ満期産の新生児を治療する方法 |
US20120177601A1 (en) * | 2009-07-02 | 2012-07-12 | The Usa As Represented By The Secretary Of The Department Of Veterans Affairs | Treatment of hepatitis c virus infections |
WO2012145520A2 (en) | 2011-04-19 | 2012-10-26 | Alfama, Inc. | Carbon monoxide releasing molecules and uses thereof |
EP2734235B1 (en) | 2011-07-21 | 2017-03-22 | Alfama, Inc. | Ruthenium carbon monoxide releasing molecules and uses thereof |
US9987302B2 (en) | 2011-08-09 | 2018-06-05 | Beth Israel Deaconess Medical Center, Inc. | Methods of treating DNA damage |
JP6457749B2 (ja) * | 2013-12-27 | 2019-01-23 | ハウスウェルネスフーズ株式会社 | Vcam−1発現抑制剤 |
TW201618795A (zh) | 2014-04-15 | 2016-06-01 | 波泰里斯股份有限公司 | 用以改良器官功能及延長器官移植物壽命之系統及方法 |
CN108057032B (zh) * | 2018-01-30 | 2020-06-05 | 中国人民解放军第二军医大学第二附属医院 | 阿尔维林在制备预防或治疗门脉高压症的药物中的应用 |
EP3524290A1 (en) * | 2018-02-09 | 2019-08-14 | Julius-Maximilians-Universitaet Wuerzburg | Method and system for monitoring carbon monoxide (co) administration to ex-vivo fluids |
Family Cites Families (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4053590A (en) * | 1975-02-27 | 1977-10-11 | Alza Corporation | Compositions of matter comprising macromolecular hemoglobin |
US4264739A (en) * | 1979-01-05 | 1981-04-28 | Merck & Co., Inc. | Sparger for cell culture system |
JPS5679957A (en) | 1979-12-05 | 1981-06-30 | Sogo Seibutsu Igaku Kenkyusho:Kk | Erucinia enterocolitica polysaccharide sensitizing blood cell and method of detecting erucinia enterocolitica polysaccharide antibody using this |
US5240912A (en) * | 1983-05-09 | 1993-08-31 | Todaro George J | Transforming growth factor (TGF) peptides |
US5084380A (en) * | 1985-01-29 | 1992-01-28 | Applied Biotechnology | Monoclonal antibodies reactive with activated and oncogenic ras p21 proteins |
US5449665A (en) * | 1985-09-24 | 1995-09-12 | Item Development Aktiebolag | Continuous intravenous infusion of adenosine to human patients undergoing percutaneous transluminal angioplasty |
DE3739650C1 (de) * | 1987-11-23 | 1989-05-24 | Immuno Ag | Fermenter zum Zuechten von Zellkulturen |
US5180366A (en) * | 1990-10-10 | 1993-01-19 | Woods W T | Apparatus and method for angioplasty and for preventing re-stenosis |
US5792325A (en) * | 1990-11-15 | 1998-08-11 | Richardson, Jr.; William H. | Electric arc material processing system |
US5293875A (en) * | 1992-06-16 | 1994-03-15 | Natus Medical Incorporated | In-vivo measurement of end-tidal carbon monoxide concentration apparatus and methods |
ATE264671T1 (de) * | 1993-02-22 | 2004-05-15 | American Bioscience Inc | Verfahren für die in-vivo-verabreichung von biologischen substanzen und hierfür verwendbare zusammensetzungen |
EP0804244A1 (en) | 1993-03-26 | 1997-11-05 | Biorelease Technologies, Inc. | Compositions including heme-containing proteins and methods relating thereto |
US5763431A (en) * | 1993-08-20 | 1998-06-09 | Jackson; Meyer B. | Method for regulating neuropeptide hormone secretion |
DE4421433C1 (de) | 1994-06-18 | 1995-06-08 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit Wirkstoffen, die Kohlenmonoxid-Quellen darstellen, Verfahren zu seiner Herstellung und seine Verwendung |
US5476764A (en) * | 1994-09-16 | 1995-12-19 | The Regents Of The University Of California | Method using CO for extending the useful shelf-life of refrigerated red blood cells |
US6066333A (en) * | 1994-09-22 | 2000-05-23 | William Harvey Research Limited | Pharmaceutical control of inflammation |
US5664563A (en) * | 1994-12-09 | 1997-09-09 | Cardiopulmonary Corporation | Pneumatic system |
US5914316A (en) * | 1994-12-16 | 1999-06-22 | Washington University | Method of inhibiting intimal hyperplasia |
US5712293A (en) * | 1995-06-07 | 1998-01-27 | Sepracor, Inc. | Methods for treating gastro-esophageal reflux disease and other disorders associated with the digestive tract using optically pure (-) norcisapride |
FR2735382B1 (fr) | 1995-06-15 | 1997-07-25 | Air Liquide | Installation de production de monoxyde de carbone incorporant une unite de separation cryogenique |
EP0835115B1 (en) * | 1995-06-30 | 2004-05-06 | ZymoGenetics, Inc. | 4-(2-(n-2-carboxamidoindole)aminoethyl)-benzenesulfonamides or sulfonylureas as pdgf antagonists |
US5702325A (en) | 1996-01-30 | 1997-12-30 | Icon Health & Fitness, Inc. | Cabinet treadmill with handle |
BR9612529A (pt) * | 1996-02-27 | 1999-08-31 | Intensive Care Innovations Ltd | Sistema ventilatório com administrador de gás adicional. |
WO1997037644A1 (en) * | 1996-04-05 | 1997-10-16 | The General Hospital Corporation | Treatment of a hemoglobinopathy |
US6069132A (en) * | 1996-08-14 | 2000-05-30 | Revanker; Ganapathi R. | Phosphazole compounds |
ATE253372T1 (de) | 1996-08-27 | 2003-11-15 | Messer Griesheim Gmbh | Wasserstoffhaltiges medikament |
WO1998013058A1 (en) * | 1996-09-27 | 1998-04-02 | The Trustees Of Columbia University In The City Of New York | Methods for treating an ischemic disorder and improving stroke outcome |
US8128963B2 (en) * | 1996-09-27 | 2012-03-06 | The Trustees Of Columbia University In The City Of New York | Methods for treating ischemic disorders using carbon monoxide |
US6316403B1 (en) * | 1996-09-27 | 2001-11-13 | The Trustees Of Columbia University In The City Of New York | Methods for treating an ischemic disorder and improving stroke outcome |
US6315995B1 (en) | 1996-09-27 | 2001-11-13 | The Trustees Of Columbia University In The City Of New York | Methods for treating an ischemic disorder and improving stroke outcome |
US5876604A (en) * | 1996-10-24 | 1999-03-02 | Compact Membrane Systems, Inc | Method of gasifying or degasifying a liquid |
TR200101501T2 (tr) | 1998-03-16 | 2002-06-21 | Celgene Corporation | 2-(2,6-dioksopiperidin-3-il)izoindolin türevleri, bunların hazırlanması ve enflamatuar sitokinlerin inhibitörleri olarak kullanımı. |
US6203991B1 (en) * | 1998-08-21 | 2001-03-20 | The Regents Of The University Of Michigan | Inhibition of smooth muscle cell migration by heme oxygenase I |
US7678390B2 (en) * | 1999-04-01 | 2010-03-16 | Yale University | Carbon monoxide as a biomarker and therapeutic agent |
US20050250688A1 (en) * | 1999-04-01 | 2005-11-10 | The Trustees Of Columbia University In The City Of New York | Methods for treating an ischemic disorder and improving stroke outcome |
US7632803B2 (en) * | 1999-10-01 | 2009-12-15 | Dmi Life Sciences, Inc. | Metal-binding compounds and uses therefor |
FR2812197B1 (fr) | 2000-07-27 | 2003-01-03 | Air Liquide Sante Int | Utilisation de co dans le traitement de l'inflammation des voies aeriennes superieures ou des bronches |
FR2812545B1 (fr) * | 2000-08-03 | 2003-03-28 | Air Liquide Sante Int | Aerosol medicamenteux inhalable dans le traitement ou la prevention de la douceur |
FR2816212A1 (fr) | 2000-11-03 | 2002-05-10 | Air Liquide Sante Int | Utilisation de monoxyde de carbone (co) dans le traitement des inflammations du systeme cardiovasculaire |
IL157580A0 (en) * | 2001-03-20 | 2004-03-28 | Glaxo Group Ltd | Inhalation drug combination |
WO2002078684A2 (en) | 2001-03-30 | 2002-10-10 | Sangstat Medical Corporation | Carbon monoxide generating compounds for treatment of vascular, inflammatory and immune disorders |
GB0111872D0 (en) | 2001-05-15 | 2001-07-04 | Northwick Park Inst For Medica | Therapeutic agents and methods |
US7122027B2 (en) * | 2001-05-25 | 2006-10-17 | Medtronic, Inc. | Implantable medical device with controllable gaseous agent release system |
MXPA03012031A (es) * | 2001-06-21 | 2005-07-01 | Univ Yale | El monoxido de carbono mejoraresultados en transplantes de tejido y organo y suprime apoptosis. |
US7174178B2 (en) | 2001-07-19 | 2007-02-06 | Intel Corporation | Deriving a more accurate estimate from prediction data in closed loop transmit diversity modes |
NZ534912A (en) | 2002-02-04 | 2007-08-31 | Alfama Investigacao E Desenvol | supramolecule aggregate comprising CO containing organometallic or transition metal complex and anti-inflammatory agent or biphosphonate phosphonate derivative |
US7364757B2 (en) * | 2002-02-13 | 2008-04-29 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Methods of treating vascular disease |
PL373002A1 (en) * | 2002-04-15 | 2005-08-08 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Methods of treating ileus |
EP1499328B1 (en) | 2002-04-15 | 2015-09-16 | University of Pittsburgh - Of the Commonwealth System of Higher Education | Methods of treating necrotizing enterocolitis |
WO2003088748A1 (en) | 2002-04-15 | 2003-10-30 | Beth Israel Deaconess Medical Center | Use of heme oxygenase-1 and products of heme degradation |
WO2003094932A1 (en) * | 2002-05-09 | 2003-11-20 | Yale University | Carbon monoxide as a biomarker and therapeutic agent |
ES2372273T3 (es) | 2002-05-17 | 2012-01-17 | Yale University | Métodos de tratamiento de la hepatitis. |
PL374375A1 (en) | 2002-06-05 | 2005-10-17 | Yale University | Methods of treating angiogenesis, tumor growth, and metastasis |
EA200500062A1 (ru) | 2002-06-21 | 2005-06-30 | Юниверсити Оф Питтсбург Оф Дзе Коммонвелт Систем Оф Хайер Эдьюкейшн | Фармацевтическое применение оксида азота, гемоксигеназы-1 и продуктов деградации гема |
DE10230165A1 (de) | 2002-07-04 | 2004-01-15 | Ino Therapeutics Gmbh | Verfahren und Vorrichtung zur Administration von Kohlenmonoxid |
EA200500782A1 (ru) | 2002-11-07 | 2005-10-27 | Юниверсити Оф Питтсбург Оф Дзе Коммонвелт Систем Оф Хайер Эдьюкейшн | Лечение геморрагического шока |
US20050255178A1 (en) | 2004-02-04 | 2005-11-17 | Bloch Kenneth D | Enhancing the effectiveness of an inhaled therapeutic gas |
-
2003
- 2003-05-16 ES ES03728926T patent/ES2372273T3/es not_active Expired - Lifetime
- 2003-05-16 PL PL374177A patent/PL205066B1/pl not_active IP Right Cessation
- 2003-05-16 JP JP2004504976A patent/JP4549847B2/ja not_active Expired - Fee Related
- 2003-05-16 CA CA002485465A patent/CA2485465A1/en not_active Abandoned
- 2003-05-16 UA UA20041210382A patent/UA83465C2/uk unknown
- 2003-05-16 AT AT03728926T patent/ATE521357T1/de not_active IP Right Cessation
- 2003-05-16 WO PCT/US2003/015263 patent/WO2003096977A2/en active Application Filing
- 2003-05-16 US US10/439,632 patent/US20040052866A1/en not_active Abandoned
- 2003-05-16 RS YUP-993/04A patent/RS99304A/sr unknown
- 2003-05-16 EP EP03728926A patent/EP1505990B1/en not_active Expired - Lifetime
- 2003-05-16 EA EA200401525A patent/EA200401525A1/ru unknown
- 2003-05-16 DK DK03728926.1T patent/DK1505990T3/da active
- 2003-05-16 CN CN038163233A patent/CN1668314B/zh not_active Expired - Fee Related
- 2003-05-16 MX MXPA04011426A patent/MXPA04011426A/es active IP Right Grant
-
2004
- 2004-11-16 HR HR20041071A patent/HRP20041071A2/xx not_active Application Discontinuation
- 2004-11-19 NO NO20045056A patent/NO20045056L/no not_active Application Discontinuation
-
2012
- 2012-07-09 US US13/544,701 patent/US20120276220A1/en not_active Abandoned
-
2013
- 2013-03-14 US US13/803,330 patent/US20130202720A1/en not_active Abandoned
- 2013-12-02 US US14/094,140 patent/US9522163B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EA200401525A1 (ru) | 2006-06-30 |
RS99304A (en) | 2007-04-10 |
CN1668314B (zh) | 2011-01-12 |
ATE521357T1 (de) | 2011-09-15 |
EP1505990A2 (en) | 2005-02-16 |
US20130202720A1 (en) | 2013-08-08 |
PL205066B1 (pl) | 2010-03-31 |
HRP20041071A2 (en) | 2005-06-30 |
CN1668314A (zh) | 2005-09-14 |
JP4549847B2 (ja) | 2010-09-22 |
CA2485465A1 (en) | 2003-11-27 |
NO20045056L (no) | 2005-02-16 |
EP1505990B1 (en) | 2011-08-24 |
US9522163B2 (en) | 2016-12-20 |
AU2003234585A1 (en) | 2003-12-02 |
DK1505990T3 (da) | 2011-11-21 |
US20120276220A1 (en) | 2012-11-01 |
EP1505990A4 (en) | 2008-02-20 |
UA83465C2 (uk) | 2008-07-25 |
US20040052866A1 (en) | 2004-03-18 |
US20140141103A1 (en) | 2014-05-22 |
PL374177A1 (en) | 2005-10-03 |
WO2003096977A3 (en) | 2004-03-11 |
WO2003096977A2 (en) | 2003-11-27 |
JP2005533021A (ja) | 2005-11-04 |
ES2372273T3 (es) | 2012-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20041071A2 (en) | Methods of treating hepatitis | |
RS91004A (en) | Methods of treating ileus | |
RS91104A (en) | Methods of treating necrotizing enterocolitis | |
PL373229A1 (en) | Method and apparatus for the administration of co | |
RS105304A (en) | Methods of treating angiogenesis,tumor growth,and metastasis | |
RS20050344A (en) | Treatment for hemorrhagic shock | |
EP1670450B8 (en) | Pharmaceutical compositions and method of using levodopa and carbidopa | |
MX349188B (es) | Sns - 595 y metodos para utilizar el mismo. | |
UA92894C2 (ru) | Способ приготовления и применения композиции адсорбента фосфата, адсорбент фосфата, композиция адсорбента фосфата | |
HK1086186A1 (en) | Use of spongosine (2-methoxyadenosein) for preparing pharmaceutical for the treatment of pain | |
MXPA05009786A (es) | Composicion para administracion de hierro para el tratamiento del sindrome de piernas inquietas. | |
MY141528A (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
PL1694354T3 (pl) | Sposób zapobiegania i leczenia cukrzycy za pomocą neurturyny | |
WO2004073615A8 (en) | Deazaflavin compounds and methods of use thereof | |
UA72927C2 (uk) | Композиція для лікування печінково-клітинного раку, що містить доцетаксель | |
WO2004004653A3 (en) | Methods for treating psychosis associated with interferon-alpha therapy | |
TW200509984A (en) | Injectable dosage form of flupirtine | |
MXPA05005915A (es) | Soluciones de albumina humana terapeutica con baja actividad del activador de precalicreina (pka) y procedimiento de obtencion de las mismas. | |
DE60335535D1 (de) | Zusammensetzung und verfahren zur abtötung von tumoren | |
PL375354A1 (en) | Use of treosulfan and derivatives thereof for treating multiple sclerosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |